PRWeb
prCenter
Dr. Philip S. Low Inducted into 2026 ACS Division of Medicinal Chemistry Hall of Fametranslating…
Purdue drug discovery pioneer and LIFT founder recognized posthumously for targeted-therapy research that yielded three FDA-approved medicines WEST LAFAYETTE, Ind., Aug. 31, 2026 /PRNewswire-PRWeb/ -- The Low Institute for Therapeutics (LIFT) today announced that its Founder…
Keywords#Low#ACS#ACS Division#Chemistry#Chemistry Hall